Do analysts prefer CEPO or THAR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cantor Equity Partners 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Tharimmune 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, CEPO or THAR?

Cantor Equity Partners is trading at a lower price-to-earnings ratio than Tharimmune, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cantor Equity Partners N/A N/A -$6.66M -$0.29 N/A Tharimmune N/A N/A -$12.20M -$3.99 N/A

Is CEPO or THAR more profitable?

Cantor Equity Partners' return on equity of 0.00% beat Tharimmune's return on equity. Company Net Margins Return on Equity Return on Assets Cantor Equity Partners N/A N/A -0.74% Tharimmune N/A -588.45% -264.41%

Do analysts rate THAR or TROO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tharimmune 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TROOPS 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, THAR or TROO?

Tharimmune has higher earnings, but lower revenue than TROOPS. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tharimmune N/A N/A -$12.20M -$3.99 N/A TROOPS $17.10M 13.07 -$27.91M N/A N/A

Is THAR or TROO more profitable?

TROOPS's return on equity of 0.00% beat Tharimmune's return on equity. Company Net Margins Return on Equity Return on Assets Tharimmune N/A -588.45% -264.41% TROOPS N/A N/A N/A

Do analysts rate MAAS or THAR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Maase 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Tharimmune 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, MAAS or THAR?

Tharimmune has lower revenue, but higher earnings than Maase. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Maase $109.05M 2.20 -$27.36M N/A N/A Tharimmune N/A N/A -$12.20M -$3.99 N/A

Is MAAS or THAR more profitable?

Maase's return on equity of 0.00% beat Tharimmune's return on equity. Company Net Margins Return on Equity Return on Assets Maase N/A N/A N/A Tharimmune N/A -588.45% -264.41%

Do analysts rate THAR or BNC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tharimmune 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CEA Industries 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate TONX or THAR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Verb Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Tharimmune 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Tharimmune (THAR) Competitors

$2.45 +0.01 (+0.41%)

As of 09/22/2026

Compare

THAR vs. CEPO, TROO, MAAS, BNC, and TONX

Should you buy Tharimmune stock or one of its competitors? Tharimmune's main competitors and comparable companies include Cantor Equity Partners (CEPO), TROOPS (TROO), Maase (MAAS), CEA Industries (BNC), and Verb Technology (TONX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does Tharimmune compare to Cantor Equity Partners?

Cantor Equity Partners (NASDAQ:CEPO) and Tharimmune (NASDAQ:THAR) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cantor Equity Partners	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Tharimmune	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cantor Equity Partners is trading at a lower price-to-earnings ratio than Tharimmune, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cantor Equity Partners	N/A	N/A	-$6.66M	-$0.29	N/A
Tharimmune	N/A	N/A	-$12.20M	-$3.99	N/A

1.2% of Tharimmune shares are held by institutional investors. 6.7% of Tharimmune shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Cantor Equity Partners' average media sentiment score of 0.00 equaled Tharimmune'saverage media sentiment score.

Company	Overall Sentiment
Cantor Equity Partners	Neutral
Tharimmune	Neutral

Cantor Equity Partners' return on equity of 0.00% beat Tharimmune's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cantor Equity Partners	N/A	N/A	-0.74%
Tharimmune	N/A	-588.45%	-264.41%

Cantor Equity Partners has a beta of -0.05, suggesting that its share price is 105% less volatile than the broader market. Comparatively, Tharimmune has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market.

Summary

Cantor Equity Partners and Tharimmune tied by winning 4 of the 8 factors compared between the two stocks.

How does Tharimmune compare to TROOPS?

Tharimmune (NASDAQ:THAR) and TROOPS (NASDAQ:TROO) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

1.2% of Tharimmune shares are held by institutional investors. 6.7% of Tharimmune shares are held by company insiders. Comparatively, 1.1% of TROOPS shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Tharimmune has higher earnings, but lower revenue than TROOPS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tharimmune	N/A	N/A	-$12.20M	-$3.99	N/A
TROOPS	$17.10M	13.07	-$27.91M	N/A	N/A

TROOPS's return on equity of 0.00% beat Tharimmune's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tharimmune	N/A	-588.45%	-264.41%
TROOPS	N/A	N/A	N/A

Tharimmune has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, TROOPS has a beta of 3.55, meaning that its stock price is 255% more volatile than the broader market.

In the previous week, TROOPS had 15 more articles in the media than Tharimmune. MarketBeat recorded 15 mentions for TROOPS and 0 mentions for Tharimmune. Tharimmune's average media sentiment score of 0.00 beat TROOPS's score of -0.40 indicating that Tharimmune is being referred to more favorably in the media.

Company	Overall Sentiment
Tharimmune	Neutral
TROOPS	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tharimmune	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TROOPS	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

TROOPS beats Tharimmune on 5 of the 9 factors compared between the two stocks.

How does Tharimmune compare to Maase?

Maase (NASDAQ:MAAS) and Tharimmune (NASDAQ:THAR) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

Tharimmune has lower revenue, but higher earnings than Maase.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maase	$109.05M	2.20	-$27.36M	N/A	N/A
Tharimmune	N/A	N/A	-$12.20M	-$3.99	N/A

1.2% of Tharimmune shares are held by institutional investors. 87.6% of Maase shares are held by insiders. Comparatively, 6.7% of Tharimmune shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Maase's return on equity of 0.00% beat Tharimmune's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Maase	N/A	N/A	N/A
Tharimmune	N/A	-588.45%	-264.41%

In the previous week, Maase had 2 more articles in the media than Tharimmune. MarketBeat recorded 2 mentions for Maase and 0 mentions for Tharimmune. Maase's average media sentiment score of 0.00 equaled Tharimmune'saverage media sentiment score.

Company	Overall Sentiment
Maase	Neutral
Tharimmune	Neutral

Maase has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market. Comparatively, Tharimmune has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Maase	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Tharimmune	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Maase beats Tharimmune on 5 of the 8 factors compared between the two stocks.

How does Tharimmune compare to CEA Industries?

Tharimmune (NASDAQ:THAR) and CEA Industries (NASDAQ:BNC) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

In the previous week, CEA Industries had 2 more articles in the media than Tharimmune. MarketBeat recorded 2 mentions for CEA Industries and 0 mentions for Tharimmune. CEA Industries' average media sentiment score of 1.15 beat Tharimmune's score of 0.00 indicating that CEA Industries is being referred to more favorably in the news media.

Company	Overall Sentiment
Tharimmune	Neutral
CEA Industries	Positive

CEA Industries has a net margin of 362.26% compared to Tharimmune's net margin of 0.00%. CEA Industries' return on equity of 64.29% beat Tharimmune's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tharimmune	N/A	-588.45%	-264.41%
CEA Industries	362.26%	64.29%	54.03%

CEA Industries has higher revenue and earnings than Tharimmune. Tharimmune is trading at a lower price-to-earnings ratio than CEA Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tharimmune	N/A	N/A	-$12.20M	-$3.99	N/A
CEA Industries	$27.99M	8.99	$115.26M	$5.53	1.10

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tharimmune	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CEA Industries	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

1.2% of Tharimmune shares are held by institutional investors. 6.7% of Tharimmune shares are held by company insiders. Comparatively, 2.7% of CEA Industries shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Tharimmune has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market. Comparatively, CEA Industries has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

Summary

CEA Industries beats Tharimmune on 10 of the 13 factors compared between the two stocks.

How does Tharimmune compare to Verb Technology?

Verb Technology (NASDAQ:TONX) and Tharimmune (NASDAQ:THAR) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability.

7.2% of Verb Technology shares are held by institutional investors. Comparatively, 1.2% of Tharimmune shares are held by institutional investors. 21.4% of Verb Technology shares are held by company insiders. Comparatively, 6.7% of Tharimmune shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Tharimmune has lower revenue, but higher earnings than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than Tharimmune, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verb Technology	$30.80M	7.22	-$148.48M	-$1.04	N/A
Tharimmune	N/A	N/A	-$12.20M	-$3.99	N/A

In the previous week, Verb Technology's average media sentiment score of 0.00 equaled Tharimmune'saverage media sentiment score.

Company	Overall Sentiment
Verb Technology	Neutral
Tharimmune	Neutral

Tharimmune has a net margin of 0.00% compared to Verb Technology's net margin of -497.15%. Verb Technology's return on equity of -60.82% beat Tharimmune's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verb Technology	-497.15%	-60.82%	-59.56%
Tharimmune	N/A	-588.45%	-264.41%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Verb Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Tharimmune	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Verb Technology has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market. Comparatively, Tharimmune has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

Summary

Verb Technology beats Tharimmune on 6 of the 10 factors compared between the two stocks.

Get Tharimmune News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

THAR vs. The Competition

Export

Metric	Tharimmune	Financial Services Industry	Finance Sector	NASDAQ Exchange
Market Cap	$92.44M	$27.39B	$13.78B	$13.29B
Dividend Yield	N/A	6.72%	5.95%	12.57%
P/E Ratio	-0.61	19.34	25.23	25.69
Price / Sales	N/A	425.22	518.37	89.15
Price / Cash	N/A	254.09	46.12	52.76
Price / Book	3.60	3.15	2.71	6.32
Net Income	-$12.20M	$1.10B	$1.31B	$359.73M
7 Day Performance	20.10%	1.99%	-0.32%	0.17%
1 Month Performance	11.87%	1.82%	-1.51%	-3.27%
1 Year Performance	-17.23%	-2.01%	8.92%	5.58%

Tharimmune Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
THAR Tharimmune	N/A	$2.45 +0.4%	N/A	-13.1%	$92.44M	N/A	N/A	2
CEPO Cantor Equity Partners	N/A	$10.78 +0.3%	N/A	+2.5%	$274.89M	N/A	N/A	2	High Trading Volume
TROO TROOPS	0.1465 of 5 stars	$2.14 +2.4%	N/A	+48.8%	$261.42M	$17.10M	N/A	47
MAAS Maase	0.1818 of 5 stars	$16.20 -3.7%	N/A	+337.8%	$257.86M	$784.35M	N/A	731	News Coverage High Trading Volume
BNC CEA Industries	1.9275 of 5 stars	$5.42 +13.9%	N/A	N/A	$223.14M	$29.33M	0.96	164	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:THAR) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tharimmune (THAR) Competitors

THAR vs. CEPO, TROO, MAAS, BNC, and TONX

How does Tharimmune compare to Cantor Equity Partners?

Summary

How does Tharimmune compare to TROOPS?

Summary

How does Tharimmune compare to Maase?

Summary

How does Tharimmune compare to CEA Industries?

Summary

How does Tharimmune compare to Verb Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

THAR vs. The Competition

Tharimmune Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tharimmune (THAR) Competitors

THAR vs. CEPO, TROO, MAAS, BNC, and TONX

How does Tharimmune compare to Cantor Equity Partners?

Do analysts prefer CEPO or THAR?

Which has better valuation and earnings, CEPO or THAR?

Do insiders & institutionals believe in CEPO or THAR?

Does the media refer more to CEPO or THAR?

Is CEPO or THAR more profitable?

Which has more risk and volatility, CEPO or THAR?

Summary

How does Tharimmune compare to TROOPS?

Do institutionals & insiders hold more shares of THAR or TROO?

Which has higher earnings & valuation, THAR or TROO?

Is THAR or TROO more profitable?

Which has more risk & volatility, THAR or TROO?

Does the media prefer THAR or TROO?

Do analysts rate THAR or TROO?

Summary

How does Tharimmune compare to Maase?

Which has higher earnings and valuation, MAAS or THAR?

Do insiders & institutionals believe in MAAS or THAR?

Is MAAS or THAR more profitable?

Does the media favor MAAS or THAR?

Which has more volatility & risk, MAAS or THAR?

Do analysts rate MAAS or THAR?

Summary

How does Tharimmune compare to CEA Industries?

Does the media refer more to THAR or BNC?

Is THAR or BNC more profitable?

Which has stronger earnings and valuation, THAR or BNC?

Do analysts rate THAR or BNC?

Do institutionals & insiders believe in THAR or BNC?

Which has more volatility and risk, THAR or BNC?

Summary

How does Tharimmune compare to Verb Technology?

Do institutionals and insiders believe in TONX or THAR?

Which has better earnings and valuation, TONX or THAR?

Does the media favor TONX or THAR?

Is TONX or THAR more profitable?

Do analysts rate TONX or THAR?

Which has more risk and volatility, TONX or THAR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

THAR vs. The Competition

Tharimmune Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools